- Shares of Can-Fite BioPharma Ltd. (NYSE:CANF) surged 30.5% after the company announced its strategic partnership with Univo to develop cannabinoid-based products is ongoing.
- Shares of Immunomedics, Inc. (NASDAQ:IMMU) gained 5.7% after the company announced that the FDA had accepted for filing the company's BLA seeking accelerated approval of sacituzumab govitecan to treat metastatic triple-negative breast cancer.
- Shares of Spring Bank Pharmaceuticals, Inc. (NASDAQ:SBPH) declined 66.8% after the company reported that it has stopped the dosing of inarigivir patients in Phase 2 program.
- Shares of QIAGEN N.V. (NYSE:QGEN) declined 20.6% after the company announced that it would not be acquired and will stay a standalone business.
QIAGEN N.V. (QGEN): Free Stock Analysis Report
Immunomedics, Inc. (IMMU): Free Stock Analysis Report
Can-Fite Biopharma Ltd (CANF): Free Stock Analysis Report
Spring Bank Pharmaceuticals, Inc. (SBPH): Free Stock Analysis Report
Original post
Zacks Investment Research